Skip to content

Immune-Pineal Axis Function in Chronic Tension-Type Headache

Immune-Pineal Axis Function in Chronic Tension-Type Headache: Noradrenergic Modulation and the Effect of Electroacupuncture

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01954277
Enrollment
34
Registered
2013-10-01
Start date
2010-10-31
Completion date
2013-11-30
Last updated
2013-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Tension-Type Headache

Keywords

Chronic Tension-Type Headache, Electroacupuncture, Headache Impact, BDNF, TNF

Brief summary

The purpose of this study is to determine whether electroacupuncture is effective in the treatment of chronic tension-type headache, measured by Headache Impact Test, Visual Analogue Scale and biomarkers.

Detailed description

Tension-type headache can be defined as a constant sensation of pressure or heaviness, and is a highly-prevalent condition in the health services. The objective of the present study is to investigate the function of the immuno-pineal axis in chronic tension headache, focussed on the neuro-immune regulatory dysfunction. In addition, the effect of neuro-stimulation (electroacupuncture) on the function of this axis will also be studied. This is a clinical Trial study, randomised, in parallel, cross-over with a blinded assessor, and with a sham placebo control. The study will be carried out in the Clinical Research Outpatient Clinic of the Hospital de Clínicas de Porto Alegre (HCPA), with women aged between 18 and 60 years old. The participants will respond to questionnaires at the beginning and end of each therapeutic intervention, with 24-hour urine, blood and saliva collection. The therapeutic intervention will include: 10 electroacupuncture sessions and 10 sham placebo sessions. The measurements taken will be: quality of life, depression, impact of headache on daily life, sleep quality, chronotropic types, immuno-inflammatory mediators, levels of 6-sulfatoxymelatonin, and salivary cortisol. Through these interventions it is hoped that patients will present an improvement in their pain presentation, quality of life and sleep, as well as central autonomic regulation. Evidence for these hypotheses will support a minimally-invasive treatment, with few side-effects and a low cost.

Interventions

DEVICEElectroacupuncture

Eletroacupuncture performed using acupuncture needles.

Placebo Sham is performed using electrodes, without electrical stimulation. Lights and sounds were identical to active treatment.

Sponsors

Federal University of Rio Grande do Sul
CollaboratorOTHER
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
CollaboratorOTHER_GOV
Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Women, * Aged between 18 and 60 years old, * Providing informed consent to participate in the study, * Literate, * Clinical diagnosis of Chronic Tension-Type Headache according to the International Headache Society.

Exclusion criteria

* Psychiatric or neurologic disorder that unable patient to consent and follow study protocol, * De-compensated systemic disease, * Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis), * HIV.

Design outcomes

Primary

MeasureTime frameDescription
Pain Visual Analogue Scale (VAS)An expected average of 3 months. (At baseline and at the end of each intervention period).The intensity of pain was measured by a 10 cm VAS. The scores range from no pain (zero) to the worst possible pain (10 cm).

Secondary

MeasureTime frameDescription
Headache Impact Test (HIT-6)An expected average of 3 months. (At baseline and at the end of each intervention period).This test was developed in 2004, and has equivalent psychometric properties in nine languages, including Portuguese. It consists of six questions that assess the impact of headache on the ability to work, study, home and in social situations.

Other

MeasureTime frameDescription
Biomarkers (BDNF nd TNF)An expected average of 3 months. (At baseline and at the end of each intervention period).The BDNF and the TNF will be measured by ELISA.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026